J. Fazekas

发表

Adjuvant hyperthermia in the irradiation of metastatic tumor masses utilizing 2450 MHz microwaves.

R. Nerlinger, F. Waterman, D. Leeper, 1982, Advances in experimental medicine and biology.

Localized hyperthermia adjuvant to irradiation in superficial recurrent carcinomas: a preliminary report on 46 patients.

R. Nerlinger, J. Fazekas, 1981, International journal of radiation oncology, biology, physics.

The relationship of nasopharyngeal carcinomas and second independent malignancies based on the radiation therapy oncology group experience

J. Cooper, T. Griffin, G. Laramore, 1991, Cancer.

Irradiation of ovarian carcinomas: a prospective comparison of the open-field and moving-strip techniques.

J. Fazekas, J. Maier, 1974, The American journal of roentgenology, radium therapy, and nuclear medicine.

Postirradiation sarcoma of the head and neck: A report of three late sarcomas following therapeutic irradiation for primary malignancies of the paranasal sinus, nasal cavity, and larynx

L. Coia, J. Fazekas, S. Kramer, 1980, Cancer.

The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).

R. Goodman, J. Fazekas, C. Mclean, 1979, International journal of radiation oncology, biology, physics.

Postirradiation induration as a prognosticator. A retrospective analysis of squamous-cell carcinomas of the oral cavity and oropharynx.

A. F. Schroeder, J. Fazekas, J. Vaeth, 1972, Radiology.

Ethnic identification with healthcare providers and treatment adherence.

J. Fazekas, L. Daratsos, J. Pelusi, 2000, Cancer practice.

Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report.

W. Curran, P. Rubin, T. Pajak, 1991, International journal of radiation oncology, biology, physics.

The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.

J. Cooper, C. Scott, T. Wasserman, 1989, International journal of radiation oncology, biology, physics.

Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck.

T. Pajak, T. Wasserman, J. Stetz, 1987, International journal of radiation oncology, biology, physics.

Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx.

J. Fazekas, S. Kramer, C. Sommer, 1980, International journal of radiation oncology, biology, physics.

Failure of misonidazole to improve outcome in advanced h&n squamous cancers

T. Wasserman, J. Fazekas, C. Scott, 1986 .

Tumor regression and other prognosticators in advanced head and neck cancers: a sequel to the RTOG methotrexate study.

J. Fazekas, C. Sommer, S. Kramer, 1983, International journal of radiation oncology, biology, physics.

Treatment of grades I and II brain astrocytomas. The role of radiotherapy.

J. Fazekas, J T Fazekas, 1977, International journal of radiation oncology, biology, physics.

Irradiation of stage I and II Hodgkin's disease.

J. Cox, J. Fazekas, W. Turner, 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.